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Background: Opportunistic oral infections can be found in over 80% of HIV + patients, often causing debilitating
lesions that also contribute to deterioration in nutritional health. Although appreciation for the role that the
microbiota is likely to play in the initiation and/or enhancement of oral infections has grown considerably in recent
years, little is known about the impact of HIV infection on host-microbe interactions within the oral cavity. In the
current study, we characterize modulations in the bacterial composition of the lingual microbiome in patients with
treated and untreated HIV infection. Bacterial species profiles were elucidated by microarray assay and compared
between untreated HIV infected patients, HIV infected patients receiving antiretroviral therapy, and healthy HIV
negative controls. The relationship between clinical parameters (viral burden and CD4+ T cell depletion) and the
loss or gain of bacterial species was evaluated in each HIV patient group.
Results: In untreated HIV infection, elevated viremia was associated with significantly higher proportions of
potentially pathogenic Veillonella, Prevotella, Megasphaera, and Campylobacter species in the lingual microbiome
than observed in healthy controls. The upsurge in the prevalence of potential pathogens was juxtaposed by
diminished representation of commensal Streptococcus and Veillonella species. Colonization of Neisseria flavescens
was lower in the lingual microbiome of HIV infected patients receiving antiretroviral therapy than in uninfected
controls.
Conclusions: Our findings provide novel insights into the potential impact of HIV infection and antiretroviral
therapy on the community structure of the oral microbiome, and implicate potential mechanisms that may increase
the capacity of non-commensal species to gain a stronger foothold.
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Human immunodeficiency virus (HIV) infection leads to
a progressive loss of CD4+ T cell numbers and function,
impairing immune responses and rendering the host
susceptible to secondary opportunistic infections [1-3].
Opportunistic infections (OI) of the oral mucosa are
presented in up to 80% of HIV-infected patients [4],
often causing debilitating lesions that contribute to de-
terioration in nutritional health. While, several studies* Correspondence: mdgeorge@ucdavis.edu
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reproduction in any medium, provided the orhave examined the effects of HIV infection on oral mu-
cosal immunity in patients with OI [5,6], questions
regarding the role of epithelial pathogenesis remain to
be answered. Although the underlying mechanisms re-
main unknown, the oral epithelium appears to be more
permeable and perturbed during HIV infection [7]. Stud-
ies in the simian immunodeficiency virus (SIV) non-
human primate model may provide some mechanistic
clues. Similar to the intestinal mucosa [8,9], SIV infec-
tion leads to a rapid down regulation of genes that medi-
ate oral epithelial regeneration [10]. In addition to
increasing barrier permeability, impairment of epithelial
regenerative capacity is likely to enhance susceptibilitytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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overlying protective microbiota (microbiome).
The human oral microbiome is a complex polymicro-
bial community in delicate balance. The microbiota con-
sists of a variety of aerobic and anaerobic species that
produce a milieu of peptides and polysaccharides that
interact with each other and with host molecules to
maintain a stable symbiotic microenvironment [11-13].
More than 700 bacterial species have been detected in
the human oral cavity, of which 35% are, so far, uncultiv-
able [14]. In healthy oral tissues, access to the epithelium
is vigorously protected from non-commensal organisms,
due in part to the physical and physiological barriers
supplied by the microbiome [15]. Microbial antigens
such as lipopolysaccharide, flagellin, peptidoglycan, and
fimbrae presumably contribute to this process as well.
These antigens differentially stimulate innate response
mechanisms through pattern recognition receptors
(PRRs) and thereby regulate the local physiological en-
vironment. In turn, the physiological constraints dictate
the corresponding profile of organisms the epithelial sur-
face can support [16,17]. Although appreciation for the
putative role that the microbiome can play in the initi-
ation and/or enhancement of oral disease has grown
considerably in recent years, little is known about the
impact of HIV infection on host-microbe interactions
within the oral cavity.
In the present study we provide, to our knowledge, the
first characterization of modulations in the dorsal
tongue (lingual) microbiota that are associated with
chronic HIV infection. Lingual bacterial species were
identified in oral swab samples utilizing the Human Oral
Microbe Identification Microarray, or HOMIM (http://
mim.forsyth.org/). Bacterial species profiles were com-
pared between untreated chronically HIV infected
patients, chronically HIV infected patients receiving
antiretroviral therapy (ART), and healthy uninfected age
matched controls. CD4+ T cell depletion and viral bur-
den were measured in peripheral blood by flow cytome-
try and Amplicor viral load assays, respectively. Our
findings provide novel insights into the impact of HIV
infection on host-microbe homeostasis within the lingual
microbiome, and reveal a potential correlation between
high viremia and colonization of several putative oppor-
tunistic pathogens in untreated patients.
Results
HIV infected patients and healthy controls harbor similar
quantities of lingual bacteria
To characterize alterations in the oral microbiome asso-
ciated with chronic HIV infection and administration of
antiretroviral therapy (ART), resident bacterial species
profiles on the dorsal tongue epithelium were compared
between 12 HIV infected patients (6 ART naïve, 6receiving ART) and 9 healthy HIV-negative controls.
The dorsal tongue surface was chosen for microbiome
sampling because that anatomical site typically displays
less sample to sample variation in microbial community
structure compared to other oral niches, and because it
is a common location for manifestation of HIV asso-
ciated oral disease (e.g. candidiasis). One of the 6 HIV
infected subjects on ART (#166) had a previous case of
thrush, diagnosed 2–3 weeks prior to collection of the
oral swab sample, but was not symptomatic or undergo-
ing antibiotic treatment at the time of sample collection.
None of the other treated or untreated HIV infected
patients in the study had been previously or concur-
rently diagnosed with candidiasis or any other HIV asso-
ciated oral complications. In addition, none of the HIV
infected or control subjects were under concurrent anti-
biotic or antimycotic treatment during the study.
Patients in the ART naïve group had been HIV positive
for at least one year, and displayed peripheral viral loads
ranging from 9 x 103 to 2 x 104 RNA copies/mL blood
and CD4+ T cells counts ranging from 525 to 137 cells/
mL blood (Table 1). All HIV patients in the treated group
had been receiving ART uninterrupted for at least 3 years,
showed undetectable peripheral viral loads, and had
CD4+ T cell counts in that ranged from 322 to 1069 cells/
mL blood. Peripheral CD4+ T cell depletion was statisti-
cally significant in the untreated HIV infected group when
compared to uninfected healthy controls (Figure 1A). HIV
patients receiving long-term ART showed significantly
higher CD4+ T cell numbers than untreated patients, al-
though not reaching the levels observed in healthy con-
trols. CD4/CD8 ratios in untreated HIV patients and HIV
patients on ART were both significantly below the levels
observed in healthy controls (Figure 1B).
To evaluate the general impact of chronic HIV infection
and ART administration on the oral microbiota, we uti-
lized the HOMIM to identify the number of bacterial spe-
cies residing on the dorsal tongue surface of HIV infected
patients and compared the species profiles to healthy con-
trols. We first compared the mean number of bacterial
species (all probes with signals ≥1) detected on the tongue
between each patient and control group (Species Score)
and found no significant differences (Figure 2A). To deter-
mine if there were differences in the total number of bac-
teria on the tongue (Bacterial Load), the total integer
score for each sample was then tallied over all the probes
on the array and mean values were compared between
controls and HIV infected groups. Similar to the Species
Score, no statistically significant difference was detected in
Bacterial Load between uninfected and infected groups
(Figure 2B). In addition, we found that Species Score and
Bacterial Load data were highly correlated in individual
samples across all experimental groups and controls
(Figure 2C). Although the Species Score and Bacterial




Gender Status ART CDA* CDA* VL+ HIV+ Time Tx Ag69e
HIV Control (n = 9) 204 F Control N/A 730 327 N/A N/A N/A 54
206 F Control N/A 510 275 N/A N/A N/A 69
213 F Control N/A 1021 382 N/A N/A N/A 43
214 F Control N/A 1559 1294 N/A N/A N/A 36
215 M Control N/A 380 290 N/A N/A N/A 57
218 M Control N/A 674 241 N/A N/A N/A 35
222 F Control N/A ND ND N/A N/A N/A 24
225 F Control N/A ND ND N/A N/A N/A 55
226 F Control N/A 1114 401 N/A N/A N/A 61
HIV ART-(n = 6) 217 M HIV+ No 307 1117 216000 9 yr None 39
224 F HIV+ No 238 1072 90000 3 yr None 39
207 F HIV+ No 151 385 55000 1.5 yr None 59
221 M HIV+ No 381 1188 50000 9 yr None 41
223 F HIV+ No 137 389 18000 1 yr None 30
212 M HIV+ No 525 873 9000 1.5y None 28
HIV + ART+ (n = 6) 158 M HIV+ Yes 873 1302 UD 23 yr 20 yr 58
166 M HIV+ Yes 540 1041 UD 13 yr 13 yr 53
205 F HIV+ Yes 1069 582 UD 15 yr 8 yr 61
208 F HIV+ Yes 322 311 UD 6 yr 3 yr 37
219 F HIV+ Yes 490 531 UD 6 yr 6 yr 44
228 M HIV+ Yes 368 582 UD 9 yr 9 yr 39
Clinical characteristics of study participants. * CD4+, CD8+ T cells/mL blood. † HIV RNA copies/mL blood. ART = antiretroviral therapy, Tx = treatment.
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species between experimental groups and controls, the
findings do indicate that the capacity of the lingual epithe-
lium to support complex polymicrobial communities was





























Figure 1 Comparison of circulating CD4+ and CD8+ T cell subsets. Th
and CD8+ T cells (B) as reported in CBC analysis of the blood of HIV- contr
receiving ART.Modulations in the lingual microbiome of HIV infected
patients
To evaluate whether HIV infection was associated with
alterations in the community structure of the lingual
microbiota in HIV patients, we next analyzed the phylo-
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Figure 2 HOMIM-based analysis of bacterial growth in the lingual microbiome. (A) Comparison of the number of bacterial species (Species
Score) detected by HOMIM assay on the tongue epithelium of healthy HIV- controls, ART naive chronically HIV infected patients, and HIV infected
patients on ART. Median values are shown in horizontal bars. (B). HOMIM-based comparison of total bacterial populations (Bacterial Load) on the
tongue epithelium of HIV- controls and HIV + patient groups. (C) Correlation between Species Score and Bacterial Load data as determined by
Spearman rank correlation coefficient analysis.
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observed in previous studies, Streptococcus species
dominated the oral microbiome of healthy subjects [18-
21], comprising ~38% of all species detected by










Figure 3 Proportional taxonomic assignments at the genus level in co
genera detected in the total lingual bacterial community in a majority of h
ART are represented by the height of their individual bars in the stacked b
genus representation, while HIV patients on ART showed a modest reductiand Rothia (~7% of all species). In total, 11 different
genera were represented in the oral microbiome of at
least one-half of all healthy controls. In contrast, 14 gen-
era were detected in ART naive HIV infected patients,
















ntrols and HIV +patient groups. The relative proportions of the
ealthy controls, untreated HIV infected patients, and HIV patients on
ar graphs. Untreated HIV patients displayed an overall increase in
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bacterium. Notably, higher representation of these 3
genera appeared to be counterbalanced by lower relative
proportions of core commensal Streptococcus and Veillo-
nella species. Thus, the taxonomic findings also sup-
ported our observations that the “Bacterial Load” and
“Species Score” generated by HOMIM analysis did not
differ significantly between treated or untreated HIV
infected groups and healthy controls.
Recent studies suggest that long-term ART may have
adverse effects on the oral health of HIV infected patients
[22]. In comparison to controls and untreated HIV
patients, only 10 genera were represented in the oral
microbiome of HIV patients undergoing ART. Represen-
tation from Lachnospiraceae and Neisseria was largely
lost, while similar to the untreated HIV+group, Mega-
sphaera colonization was higher than observed in healthy
subjects. While not reaching statistical significance, the
loss in prevalence of Neisseria flavescens was most strik-
ing, colonizing the microbiome of 67% of uninfected con-
trols and untreated HIV patients, but only 17% (one
subject) of HIV patients on ART. These data may be not-
able in light of reports that have linked reduced oral
colonization by N. flavescens with increased incident of
caries [23]. In agreement with Bacterial Load findings
(Figure 2B), the lower relative proportions of Lachnospira-
ceae and Neisseria observed in the microbiome of HIV















Figure 4 Proportions of taxonomic assignments at the genus level in
proportions of the genera detected in the total lingual bacterial communit
distribution profiles were identified in 3 untreated HIV infected patients (20higher relative proportions of other genera. In addition to
Megasphaera, HIV patients on ART showed substantially
higher colonization of Streptococcus species when com-
pared to healthy controls and the ART naïve HIV+group.
Collectively, these findings indicate that administration of
ART may lead to alterations in the phylogenetic profile of
the oral microbiota that are fundamentally distinct from
the changes associated with untreated HIV infection.
Association between HIV burden and colonization by
potential opportunistic pathogens
When the phylogenetic distribution of oral bacteria was
evaluated in each patient individually, a substantial
amount of variability within the experimental groups
and controls was revealed (Figure 4). However, despite
this variability, the phylogenetic profiles of 3 of the un-
treated HIV infected patients (207, 217, and 224 – la-
belled in red text) were strikingly similar. Further
examination revealed that these 3 patients also displayed
the highest levels of viral burden in our study cohort,
and that each of the patients had <350 CD4+ T cells/
mL of blood. Correlative analyses were then performed
to evaluate the potential relationship between clinical
parameters (viral replication and CD4+ T cell depletion)
and modulations in the oral microbiome (Bacterial Load
and Species Score data). Although data from additional
samples will be needed to validate the trend, we


















individual control subjects and HIV+patients. The relative
y of each study participant are represented in pie charts. Similar genus
7, 217, and 224: labelled in red text).
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patients (Figure 5). A similar potential correlation was
also observed between viral loads and Species Score
(data not shown). Depletion of CD4+ T cells in the un-
treated HIV+ group showed a similar but weaker trend
towards correlation with Bacterial Load and Species
Score. However, as with viral loads, high standard de-
viations associated with relatively small sample sizes
prevented us from definitively linking CD4+ T cell de-
pletion with differences in the oral microbiota between
untreated HIV patients and healthy controls.
We next analyzed differences in the prevalence of indi-
vidual bacterial species between untreated HIV infected
patients and healthy controls. Although differences in the
abundance of several species approached statistical signifi-
cance when comparing the untreated HIV infected group
as a whole to controls, these differences often became sig-
nificant when comparing HIV infected patients with high
viral loads (HVL). We defined HVL, for the purposes of
our study, as viral burden ≥50 K HIV copies/mL blood.
Veillonella parvula was the lone exception, displaying a
significant difference in abundance (P= 0.042) from unin-
fected controls across the entire untreated HIV infected
group (Figure 6A). We detected significant differences
between HVL HIV patients and uninfected controls in
the prevalence of Campylobacter concisus and/or Cam-
pylobacter rectus [cross-hybridizing HOMIM probe]
(P=0.032), Prevotella pallens (P=0.027), and Mega-
sphaera micronuciformis (P= 0.031) (Figures 6B-6D).
Interestingly, most of the species displaying higher preva-
lence in HVL HIV patients have also been linked to peri-
odontal pathogenesis, and M. micronuciformis has been
identified in previous studies through its association with
serious clinical infections [24]. Taken together, the pres-
ence of potential bacterial pathogens at higher abundance





























Figure 5 Relationship between HIV burden and increased
bacterial growth in the oral microbiome. The relationship
between viral loads in peripheral blood and the gain of bacterial
growth (Bacterial Load score identified by HOMIM analysis) in ART
naïve HIV infected patients was determined by Spearman rank
correlation coefficient analysis. HIV infected patients that showed
similar oral microbiome profiles are labelled in red text.lower abundance than healthy controls indicates that un-
controlled HIV infection may be associated with a funda-
mental shift in the character of host-microbe interactions
within the oral microbiome.Discussion
Maintenance of oral health is dependent on preserving
the homeostatic balance between host and the distinct mi-
crobial communities that colonize the various anatomical
microenvironments in the oral cavity. HIV infected
patients often display increased susceptibility to opportun-
istic oral infections that are presumably linked, in part, to
disruption of host-microbe homeostasis (dysbiosis). In the
current study, we utilize HOMIM-based analyses to
characterize and compare the bacterial composition of the
lingual microbiome in a relatively small, but well-defined
cohort of untreated chronically HIV infected patients
(n= 6), HIV patients on ART (n= 6), and uninfected con-
trols (n= 9). Due to the small sample sizes, it is important
to caution that our findings represent a preliminary indi-
cation of the impact of HIV infection on the community
structure of the oral microbiome. Indeed, the microbiome
of even a single individual can be difficult to define, con-
sisting of entrenched endogenous species and transient
species whose prevalence can vary depending on time of
sampling, diet, oral hygiene, and numerous other para-
meters [19]. Extensive cross sectional and longitudinal
sampling of patients with and without oral manifestations
will ultimately be necessary to fully characterize the role
of the microbiota in HIV associated oral pathogenesis.
The current study represents an important first step to-
wards that goal. Our findings indicate that chronic HIV
infection may lead to substantial disruptions in the com-
munity structure of the lingual microbiota, even in the ab-
sence of clinical oral manifestations.
Several potential mechanisms that have been revealed
in previous studies may contribute to the development
of host-microbe dysbiosis in the oral mucosa during im-
munodeficiency virus infection. Recently, analysis of SIV
infected rhesus macaques demonstrated that, similar to
the gut mucosa, depletion of CD4+ T cells from the oral
mucosa is rapid and dramatic [10]. This finding under-
scores the likelihood that immune dysfunction resulting
from the loss of CD4+ T cell activity in the oral cavity
could contribute to the development of oral manifesta-
tions during SIV/HIV infection. Recent studies suggest
that Notch-1 signaling mediates epithelial barrier func-
tion in the gut through interaction with CD4+ T cells
[25]. Although interaction of Notch-1 with CD4+ T cells
has not been studied in the oral mucosa, Notch-1 signal-
ing is known to mediate oral epithelial cell differenti-
ation [26]. Thus, it is possible that CD4+ T cell
depletion from the oral mucosa of HIV infected subjects
Figure 6 Emergence of opportunistic pathogens in the oral microbiome of ART naive HIV infected patients. (A) A statistically significant
increase in the growth of Veillonella parvula was detected amongst all untreated HIV + subjects, while growth of (B) Campylobacter concisus/rectus,
(C) Prevotella pallens, and (D) Megasphaera micronuciformis was significantly increased in untreated patients with HIV loads≥ 50 K/mL of blood.
Statistical analysis was performed using Wilcoxon rank-sum tests.
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and, by extension, host-microbe dysbiosis.
In addition, depletion of the Th17 subset of CD4+ T
cells has been shown in the gut mucosa impair response
to microbial infections [8,27], in part by dampening ex-
pression of epithelial antimicrobial peptides [28]. HIV
patients display decreased expression of histatin-5, a po-
tent antimycotic known to inhibit the growth of Can-
dida albicans [29]. Moreover, in vitro studies suggest
that X4-tropic HIV can inhibit expression of human beta
defensin-2 (hBD-2) and other innate immune factors in
differentiated oral epithelium [30]. Because hBD-2 func-
tions as a chemoattractant for dendritic cells in addition
to its antimicrobial activity [31], the loss of hBD-2 dur-
ing HIV infection could potentiate the colonization of
pathogenic species through multiple mechanisms. Thus,
it is conceivable that, similar to the gut mucosa, Th17
cells may be depleted from the oral mucosa in SIV/HIV
infection, thereby providing a potential mechanism for
increased susceptibility to dysbiosis and infection from
C. albicans and other non-commensal pathogens.Interestingly, one of the largest and most consistent
alterations we detected in the oral microbiome of un-
treated HIV patients was a shift in the representation of
Veillonella species. Although the relative percentage of
Veillonella dropped from ~19% of the total lingual bacter-
ial population in healthy controls to just over 10% in un-
treated HIV infected subjects, that same group displayed a
uniform increase in the growth of V. parvula. While V.
parvula is a commensal gram negative anaerobic coccus
in healthy individuals [32], it is also the only known Veillo-
nella species associated with oral disease. V. parvula has
been implicated in severe early childhood caries [33], pri-
mary endodontic infections [34], and other periodontal
diseases [35]. Recent studies indicate that V. parvula
lipopolysaccharide (LPS) stimulates pro-inflammatory
cytokine production and p38 MAPK activation through
TLR-4 dependent mechanisms [36]. Thus, it is possible
that increased V. parvula colonization (as well as other
opportunistic pathogens) could establish an inflammatory
environment in the oral cavity, that in turn, contributes to
the chronic inflammation and immune activation that
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warranted to determine whether increased colonization of
putative periodontal pathogens on the tongue epithelium
reflects similar increased growth in gingival and subgingi-
val tissues, and perhaps a systemic distribution to more
distal mucosal compartments.
Conclusions
In summary, we identify statistically significant increases
in the growth of V. parvula, P. pallens, C. rectus and/or
C. concisus, and M. micronuciformis in the lingual
microbiome of untreated HIV infected subjects, albeit a
small patient cohort where previous oral infections
could not be considered. Due to advances in therapeutic
efficacy and clinical care in developed countries, suscep-
tibility of HIV patients to opportunistic oral infections
has been dramatically reduced [37,38]. However, world-
wide, where the vast majority of HIV infected individuals
do not have access to basic clinical care or therapy, oral
complications remain a serious problem [39,40]. Large-
scale sampling from an appropriate range of geographic
and cultural regions and collation of data from multiple
studies will lead to a more complete understanding of
host-microbe dysbiosis in HIV infection. To that end,
the HOMIM and similar high throughput methodologies
designed for rapid identification of microbial profiles
may represent ideal cost-effective tools for accomplish-
ing such ambitious large-scale endeavors.
Methods
Patients and sample collection
All participants were enrolled through the Center for
AIDS Research, Education and Services (CARES) clinic
in Sacramento, CA after providing informed written
consent. The research was carried out according to Insti-
tutional Review Board (IRB)-approved procedures
(219139–5) and in compliance with the Helsinki Declar-
ation. The oral health status of each patient was deter-
mined prior to participation in the study, including any
recent or concurrent periodontal procedures and history
of candidiasis and other oral infections. Patients under-
going antibiotic or antimycotic treatment were excluded
from the study. Pertinent clinical data was also obtained
on all participants. These data included duration of HIV
infection, CBC with differential, CD4+/CD8+ T cell
numbers (blood was not collected from 2 of the 9 unin-
fected control subjects), peripheral blood HIV viral
loads, and duration of antiretroviral therapy. Peripheral
blood viral load assays were performed at the CARES
clinical lab using the Amplicor HIV-1 Assay (Roche Mo-
lecular Diagnostics). Two-sided Satterthwaite’s and
Student’s t-tests were utilized to determine the statistical
significance of differences in T cell subsets between un-
infected controls and HIV infected patient groups.During the same clinical appointment that blood sam-
ples were obtained, tongue epithelial samples were col-
lected utilizing non-invasive swabbing of the dorsal
surface. Briefly, MasterAmp Buccal Swabs© (Epicentre
Biotechnologies, Inc) were used to collect epithelial cells
and resident microbes, and DNA was extracted utilizing
the protocols and reagents provided in the Epicentre
MasterAmp© kit. Extracted DNA was transferred into
new tubes and stored at −20°C until HOMIM analysis.
HOMIM processing
Identification of oral bacterial species and quantitation of
their relative proportions was carried out using the Human
Oral Microbe Identification Microarray, or HOMIM
[41]. Briefly, 16 S rRNA genes (rDNAs) were PCR amp-
lified utilizing a universal primer set (forward primer, 5'-
GAG AGT TTG ATY MTG GCT CAG; reverse primer,
5'- GAA GGA GGT GWT CCA RCC GCA), and Cy3-
dCTP-labeled. Purified, labelled 16 S amplicons were
then hybridized to the printed HOMIM slides at 55°C
for 16 h. Hybridized slides were washed and dried and
Cy3 fluorescence was detected using the GenePix 4000B
microarray scanner (Axon) with photomultiplier set-
tings (PMT) of 650 and wavelength of 532 nm.
Analysis of HOMIM data
Analysis of HOMIM data was performed as previously
described [42,43]. Briefly, hybridization spot intensities
were converted to one of the 6 integer signal levels ran-
ging from 0 to 5, with 0 representing undetectable (above
background) and 5 being the maximal intensity among all
the profiles being compared. The number of bacterial spe-
cies (Species Score) present in each sample was deter-
mined by summation of all probes with detectable signal
(integer score≥ 1), and a qualitative representation of the
total bacteria (Bacterial Load) in each sample was esti-
mated by summation of all integer scores. Correlations be-
tween “Species Score” and “Bacterial Load” were analyzed
using Spearman rank correlation coefficient. Correlations
between clinical parameters (viral loads, CD4+ T cell
counts) and a gain or loss of oral bacteria were identified
by Spearman rank correlation coefficient analysis. Wil-
coxon rank-sum tests were utilized to determine if
increases or decreases in individual bacterial species in
HIV patient groups were statistically significant compared
to healthy HIV- controls. The HOMIM data utilized in
the study has been deposited in the Gene Expression
Omnibus microarray database (Accession#: GSE38908).
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